Zobrazeno 1 - 10
of 741
pro vyhledávání: '"Libertini, S."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Yasuda S; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kawasaki, Japan., Bando K; Sumitomo Pharma Co., Ltd., Kobe, Japan., Henry MP; Cell and Gene Therapy Catapult, London, United Kingdom., Libertini S; Biomedical Research, Novartis, Basel, Switzerland., Watanabe T; Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Bando H; Minaris Regenerative Medicine, Yokohama, Japan., Chen C; Health and Environmental Sciences Institute, Washington, DC, United States., Fujimori K; Sumitomo Pharma Co., Ltd., Kobe, Japan., Harada K; Takeda Pharmaceutical Company Limited, Fujisawa, Japan., Kuroda T; Division of Cell-Based Therapeutic Products, National Institute of Health Sciences, Kawasaki, Japan., Lemmens M; Biomedical Research, Novartis, Basel, Switzerland., Marginean D; Cell and Gene Therapy Catapult, London, United Kingdom., Moss D; Cell and Gene Therapy Catapult, London, United Kingdom., Pereira Mouriès L; Health and Environmental Sciences Institute, Washington, DC, United States., Nicholas NS; Cell and Gene Therapy Catapult, London, United Kingdom., Smart MJK; Cell and Gene Therapy Catapult, London, United Kingdom., Terai O; Sumitomo Pharma Co., Ltd., Kobe, Japan., Sato Y; Division of Drugs, National Institute of Health Sciences, Kawasaki, Japan.
Publikováno v:
Stem cells translational medicine [Stem Cells Transl Med] 2024 Oct 10; Vol. 13 (10), pp. 1001-1014.
Autor:
Klapwijk JC; Cornelis Consulting Ltd, London, United Kingdom., Del Rio Espinola A; GentiBio Inc., Cambridge, Massachusetts, USA., Libertini S; Novartis Biomedical Research, Basel, Switzerland., Collin P; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Fellows MD; Clinical Pharmacology and Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Jobling S; TestaVec Ltd, Maidenhead, United Kingdom.; Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Lynch AM; GlaxoSmithKline, Genetic Toxicology, Ware, United Kingdom., Martus H; Novartis Biomedical Research, Basel, Switzerland., Vickers C; National Centre for the Replacement Refinement and Reduction of Animals in Research, London, United Kingdom., Zeller A; F. Hoffmann-La Roche Ltd., pRED, Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Biasco L; UCL Zayed Centre for Research (ZCR), London, United Kingdom., Brugman MH; Cell and Gene Therapy, GSK Medicine Research Centre, Stevenage, United Kingdom., Bushmann FD; Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, Pennsylvania, Pennsylvania, USA., Cathomen T; Institute for Transfusion Medicine and Gene Therapy, Medical Center- University of Freiburg, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany., Ertl HCJ; Ertl Laboratory, Vaccine & Immunotherapy Center, The Wistar Institute, Philadelphia, Pennsylvania, USA., Gabriel R; ProtaGene CGT, Heidelberg, Germany., Gao G; Horae Gene Therapy Center, UMass Chan Medical School, University of Massachusetts, Worcester, Massachusetts, USA., Jadlowsky JK; Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Kimber I; Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Lanz TA; Drug Safety Research & Development, Pfizer, Inc., Groton, Connecticut, USA., Levine BL; Center for Cellular Immunotherapies and Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA., Micklethwaite KP; Department of Haematology, Blood Transplant and Cell Therapies Program, Westmead Hospital, Sydney, Australia.; NSW Health Pathology Blood Transplant and Cell Therapies Laboratory - ICPMR Westmead, Sydney, Australia.; Westmead Institute for Medical Research, Sydney, Australia.; Sydney Medical School, The University of Sydney, Sydney, Australia., Onodera M; Gene & Cell Therapy Promotion Center, National Center for Child Health and Development, Tokyo, Japan., Pizzurro DM; Merck & Co., Inc., Boston, Massachusetts, USA., Reed S; Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, United Kingdom., Rothe M; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Sabatino DE; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Salk JJ; Department of Medicine, Divisions of Hematology and Medical Oncology, University of Washington School of Medicine, Seattle, Washington, USA.; TwinStrand Biosciences Inc., Seattle, Washington, USA., Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts, USA., Themis M; TestaVec Ltd, Maidenhead, United Kingdom.; Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Yuan J; Kymera Therapeutics, Watertown, Massachusetts, USA.
Publikováno v:
Human gene therapy [Hum Gene Ther] 2024 Aug; Vol. 35 (15-16), pp. 527-542.
Autor:
Sato, Y., Bando, H. *, Di Piazza, M., Gowing, G., Herberts, C., Jackman, S., Leoni, G., Libertini, S., MacLachlan, T., McBlane, J.W., Pereira Mouriès, L., Sharpe, M., Shingleton, W., Surmacz-Cordle, B., Yamamoto, K., van der Laan, J.W. *
Publikováno v:
In Cytotherapy November 2019 21(11):1095-1111
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
West, J.M., Jones, D.G., Annunziatellis, A., Barlow, T.S., Beaubien, S.E., Bond, A., Breward, N., Coombs, P., de Angelis, D., Gardner, A., Gemeni, V., Graziani, S., Green, K.A., Gregory, S., Gwosdz, S., Hannis, S., Kirk, K., Koukouzas, N., Krüger, M., Libertini, S., Lister, T.R., Lombardi, S., Metcalfe, R., Pearce, J.M., Smith, K.L., Steven, M.D., Thatcher, K., Ziogou, F.
Publikováno v:
In International Journal of Greenhouse Gas Control November 2015 42:357-371
Autor:
Retson L; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ 85016, USA., Tiwari N; Pathology & Laboratory Medicine, Phoenix Children's Hospital, Phoenix, AZ 85016, USA., Vaughn J; Department of Radiology, Phoenix Children's Hospital, Phoenix, AZ 85016, USA., Bernes S; Department of Neurology, Phoenix Children's Hospital, Phoenix, AZ 85016, USA., Adelson PD; Department of Neurosurgery, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV 26506, USA., Mansfield K; Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Libertini S; Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Kuzmiski B; Novartis Institutes for BioMedical Research, Cambridge, MA 02139, USA., Alecu I; Novartis Pharmaceuticals, 4056 Basel, Switzerland., Gabriel R; ProtaGene CGT GmbH, 74076 Heidelberg, Germany., Mangum R; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ 85016, USA; Department of Child Health, University of Arizona College of Medicine, Phoenix, AZ, USA; Creighton University School of Medicine, Phoenix, AZ 85012, USA; Mayo Clinic Alix School of Medicine, Phoenix, AZ 85054, USA. Electronic address: mmangum@phoenixchildrens.com.
Publikováno v:
Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2023 Oct 04; Vol. 31 (10), pp. 2991-2998. Date of Electronic Publication: 2023 Aug 19.
Autor:
Ziogou, F., Gemeni, V., Koukouzas, N., de Angelis, D., Libertini, S., Beaubien, S.E., Lombardi, S., West, J.M., Jones, D.G., Coombs, P., Barlow, T.S., Gwosdz, S., Krüger, M.
Publikováno v:
In Energy Procedia 2013 37:3521-3528
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lemmens M; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland; Division of Molecular and Systems Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Perner J; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Potgeter L; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Zogg M; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Thiruchelvam S; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Müller M; Chemical Biology and Therapeutics Department, Novartis Institutes for BioMedical Research, Basel, Switzerland., Doll T; Chemical Biology and Therapeutics Department, Novartis Institutes for BioMedical Research, Basel, Switzerland., Werner A; Chemical Biology and Therapeutics Department, Novartis Institutes for BioMedical Research, Basel, Switzerland., Gilbart Y; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Couttet P; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Martus HJ; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland., Libertini S; Preclinical Safety Department, Translational Medicine, Novartis Institutes for BioMedical Research, Basel, Switzerland. Electronic address: silvana.libertini@novartis.com.
Publikováno v:
Cytotherapy [Cytotherapy] 2023 Jan; Vol. 25 (1), pp. 59-67. Date of Electronic Publication: 2022 Oct 29.